C. Russell Trenary III
2022
In 2022, C. Russell Trenary III earned a total compensation of $1.3M as President and Chief Executive Officer at Outlook Therapeutics, a 82% decrease compared to previous year.
Compensation breakdown
| Bonus | $195,462 |
|---|---|
| Option Awards | $513,650 |
| Salary | $600,000 |
| Other | $24,068 |
| Total | $1,333,179 |
Trenary received $600K in salary, accounting for 45% of the total pay in 2022.
Trenary also received $195.5K in bonus, $513.7K in option awards and $24.1K in other compensation.
Rankings
In 2022, C. Russell Trenary III's compensation ranked 2,391st out of 5,401 executives tracked by ExecPay. In other words, Trenary earned more than 55.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,391 out of 5,401 | 56th |
Division Manufacturing | 1,315 out of 2,936 | 55th |
Major group Chemicals And Allied Products | 589 out of 1,312 | 55th |
Industry group Drugs | 543 out of 1,217 | 55th |
Industry Biological Products, Except Diagnostic Substances | 141 out of 284 | 50th |
Source: SEC filing on February 15, 2023.
Trenary's colleagues
We found two more compensation records of executives who worked with C. Russell Trenary III at Outlook Therapeutics in 2022.